Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKesson
McKinsey
Express Scripts
AstraZeneca
Boehringer Ingelheim

Last Updated: June 28, 2022

CLINICAL TRIALS PROFILE FOR CEFTOBIPROLE


✉ Email this page to a colleague

« Back to Dashboard

Clinical Trials for Ceftobiprole

Trial ID Title Status Sponsor Phase Summary
NCT00210899 ↗ Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections Completed Basilea Pharmaceutica Phase 3 The purpose of this study is to compare the clinical cure rate of ceftobiprole medocaril versus a comparator in the treatment of patients with complicated skin and skin structure infections. The study will also characterize the safety and tolerability of treatment with ceftobiprole medocaril in patients with complicated skin and skin structure infections.
NCT00210964 ↗ Ceftobiprole in Hospital Acquired Pneumonia Completed Basilea Pharmaceutica Phase 3 The purpose of this study is to compare the clinical cure rate of ceftobiprole medocaril (the water-soluble prodrug [form] of ceftobiprole) referred to as ceftobiprole versus a comparator in the treatment of patients with nosocomial pneumonia.
NCT00228982 ↗ Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections Completed Basilea Pharmaceutica Phase 3 The purpose of this study is to compare the clinical cure rate of ceftobiprole medocaril versus a comparator in the treatment of patients with complicated skin and skin structure infections.
>Trial ID >Title >Status >Phase >Summary

Clinical Trial Conditions for Ceftobiprole

Condition Name

Condition Name for
Intervention Trials
Staphylococcal Skin Infections 6
Pneumonia 4
Streptococcal Infections 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for
Intervention Trials
Communicable Diseases 8
Infections 8
Infection 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Ceftobiprole

Trials by Country

Trials by Country for
Location Trials
United States 24
Greece 4
Hungary 3
Bulgaria 3
France 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for
Location Trials
California 3
Nevada 2
Montana 2
Florida 2
North Carolina 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Ceftobiprole

Clinical Trial Phase

Clinical Trial Phase for
Clinical Trial Phase Trials
Phase 3 9
Phase 2 2
Phase 1 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for
Clinical Trial Phase Trials
Completed 15
Terminated 3
Withdrawn 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Ceftobiprole

Sponsor Name

Sponsor Name for
Sponsor Trials
Basilea Pharmaceutica 19
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 3
Department of Health and Human Services 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for
Sponsor Trials
Industry 22
Other 5
U.S. Fed 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Merck
Colorcon
Mallinckrodt
Baxter
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.